Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (51890)	2/18/2000 9:03:00 AM
From: unclewest	Read Replies (1) \| Respond to of 122087

anthony....imcl do you know the conversion price? does this concern you? tia, unclewest Friday February 18, 6:33 am Eastern Time Company Press Release ImClone to Offer $150 Million in Convertible Subordinated Notes NEW YORK--(BW HealthWire)--Feb. 18, 2000--ImClone Systems Incorporated (Nasdaq:IMCL - news) announced today that it intends to offer, subject to market and other conditions, $150 million principal amount of Convertible Subordinated Notes (plus an additional amount to cover over allotments if any) due 2005. The Notes will not be registered under the Securities Act of 1933, as amended, and will be offered through initial purchasers to qualified institutional buyers under Rule 144A of the Securities Act. The Notes would be convertible into ImClone Systems common stock at the option of the holder, at a price to be determined. The net proceeds of the proposed offering would be used to fund research, development and clinical activities, as well as working capital and general corporate purposes. This announcement is neither an offer to sell nor a solicitation of an offer

To: Anthony@Pacific who wrote (51890)	2/18/2000 11:03:00 AM
From: chris	Respond to of 122087

Anthony, please read your Private messages on SI.